A Review of Our IPO Calls in 2025
In this insight, we review our IPO calls in 2025. The accuracy rate of our calls on the IPOs this year was 64%. The overall sentiment on IPOs in...
394 Views
Aimed Bio IPO Book Building Results Analysis
Aimed Bio finalized its IPO price at 11,000 won, which is at the high end of the IPO price range. Aimed Bio will be listed on KOSDAQ on 4 December....
262 Views
Aimedbio IPO Valuation Analysis
Our base case valuation of Aimedbio is implied market cap of 882 billion won or target price of 13,256 won per share over a one year view in 2026.
631 Views
Aimedbio IPO Preview
Aimedbio is getting ready to complete its IPO in KOSDAQ in November 2025. Aimedbio has advanced multiple antibody-drug conjugates (ADC) candidates...
615 Views
No more insights